Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy Kyriaki IoannouPinelopi SamaraOurania E. Tsitsilonis Review 26 February 2012 Pages: 599 - 614
Long-term proliferation of functional human NK cells, with conversion of CD56dim NK cells to a CD56bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12 Alexander C. DowellKimberley A. OldhamPeter F. Searle Original article 22 October 2011 Pages: 615 - 628
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission Christina S. ChuJean BoyerCarl H. June Original Article 22 October 2011 Pages: 629 - 641
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice Melisa J. HamiltonJudit P. BanáthKevin L. Bennewith Original article 22 October 2011 Pages: 643 - 654
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma Jun ZhouNoah K. YuenF. Stephen Hodi Original article Open access 28 October 2011 Pages: 655 - 665
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells Nanae HarashimaTohko InaoMamoru Harada Original article 29 October 2011 Pages: 667 - 676
A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo Jinpiao LinRongfen HuoNingli Li Original Article 03 November 2011 Pages: 677 - 687
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy Laurence M. WoodZhen-Kun PanYvonne Paterson Original article 06 November 2011 Pages: 689 - 700
Scutellaria extract and wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-β1 activity Sagar DandawateLinford WilliamsPrahlad Parajuli Original article 06 November 2011 Pages: 701 - 711
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C Adam E. SnookMichael S. MageeScott A. Waldman Original article 06 November 2011 Pages: 713 - 723
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy Gustav J. UllenhagArian M. SadeghiThomas H. Tötterman Original article 23 December 2011 Pages: 725 - 732
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab Vafa ShahabiGena WhitneyJeffrey R. Jackson Short communication 01 March 2012 Pages: 733 - 737
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011 Natalia AptsiauriTeresa CabreraFederico Garrido Meeting report 21 February 2012 Pages: 739 - 745
Comment on “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” by Gustav J. Ullenhag et al. Inge Marie Svane Letter to the editors 20 March 2012 Pages: 747 - 747
Response to the letter to the editors from Inge Marie Svane on our manuscript “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” Gunnar WageniusGustav J. UllenhagThomas H. Tötterman Letter to the editors 31 March 2012 Pages: 749 - 749